Therapeutic potential of angiotensin II receptor antagonists

被引:12
|
作者
White, M [2 ]
Racine, N
Ducharme, A
de Champlain, J
机构
[1] Univ Montreal, Dept Physiol, Montreal, PQ H1T 1C8, Canada
[2] Montreal Heart Inst, Montreal, PQ H1T 1C8, Canada
关键词
angiotensin II; angiotensin receptor blockade; cardiovascular function;
D O I
10.1517/13543784.10.9.1687
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The circulating renin angiotensin system plays an important role in cardiovascular homeostasis. More importantly, the local tissue renin angiotensin plays a pivotal role in cell growth and remodelling of cardiomyocytes and on the peripheral arterial vasculature. in addition, the renin angiotensin system is related to apoptosis, control of baroreflex and autonomic responses, vascular remodelling and regulation of coagulation, inflammation and oxidation. The cardioprotective and vascular protective effects of the angiotensin receptive blockade appears to be related to selective blockade of the Type I angiotensin II receptors. However, there is now growing evidence showing that some of the effects of angiotensin II receptor blockers (ARBs) are related to the activation of the kinin pathways. This paper will review some of the recent mechanisms related to the cardiovascular effects of angiotensin and more specifically of ARBs. This paper will present the novel data on the role of ARB in the development of atherosclerosis, vascular remodelling, coagulation balance and autonomic regulation. Finally, the role of ARBs, used alone or in combination with ACE inhibitor in patients with heart failure, will be discussed.
引用
收藏
页码:1687 / 1701
页数:15
相关论文
共 50 条
  • [41] Renal effects of angiotensin II receptor antagonists
    Burgess, E
    BLOOD PRESSURE, 2001, 10 : 17 - 20
  • [42] Therapeutic Potential of Vasopressin Receptor Antagonists
    Farhan Ali
    Maya Guglin
    Peter Vaitkevicius
    Jalal K. Ghali
    Drugs, 2007, 67 : 847 - 858
  • [43] Therapeutic potential of vasopressin receptor antagonists
    Ali, Farhan
    Guglin, Maya
    Vaitkevicius, Peter
    Ghali, Jalal K.
    DRUGS, 2007, 67 (06) : 847 - 858
  • [44] The therapeutic potential of angiotensin II receptor blockers in the treatment of heart failure
    McKelvie, RS
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2004, 13 (03) : 245 - 253
  • [45] Non-peptide angiotensin II receptor antagonists - Potential drugs against hypertension
    Lasikova, A
    Vegh, D
    Smahovsky, V
    CHEMICKE LISTY, 1998, 92 (02): : 133 - 146
  • [46] Angiotensin II receptor antagonists (AIIRA) and new therapeutic applications: atrial fibrillation and diastolic dysfunction
    Rosei, EA
    DISEASE MANAGEMENT & HEALTH OUTCOMES, 2005, 13 : 13 - 16
  • [47] NEW THERAPEUTIC AGENTS IN THE MANAGEMENT OF HYPERTENSION - ANGIOTENSIN II-RECEPTOR ANTAGONISTS AND RENIN INHIBITORS
    FOOTE, EF
    HALSTENSON, CE
    ANNALS OF PHARMACOTHERAPY, 1993, 27 (12) : 1495 - 1503
  • [48] Stimulation of endothelial progenitor cells - A new putative therapeutic effect of angiotensin II receptor antagonists
    Bahlmann, FH
    de Groot, K
    Mueller, O
    Hertel, B
    Haller, H
    Fliser, D
    HYPERTENSION, 2005, 45 (04) : 526 - 529
  • [49] Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists
    Kyrmizakis, DE
    Papadakis, CE
    Liolios, AD
    Karatzanis, AD
    Malandrakis, S
    Skoulakis, CE
    Bizakis, JG
    Velegrakis, GA
    ARCHIVES OF OTOLARYNGOLOGY-HEAD & NECK SURGERY, 2004, 130 (12) : 1416 - 1419
  • [50] Clinical differences among angiotensin II receptor antagonists
    Mancia, G
    BLOOD PRESSURE, 2001, 10 : 19 - 24